This Article Full Text Free Full Text (PDF) Free Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by McManus, L. M. Articles by Pinckard, R. N. Search for Related Content PubMed PubMed Citation Articles by McManus, L. M. Articles by Pinckard, R. N.

(Journal of Leukocyte Biology. 2001;70:395-404.)
© 2001 by Society for Leukocyte Biology

Agonist-dependent failure of neutrophil function in diabetes correlates with extent of hyperglycemia

Linda M. McManus^*,, Rebecca C. Bloodworth^*, Thomas J. Prihoda^*,, Janet L. Blodgett and R. Neal Pinckard^*,

Departments of
^* Pathology,
Periodontics,
Psychiatry, and
Medicine, The University of Texas Health Science Center and
^|| South Texas Veterans Administration Hospital, San Antonio, Texas

Correspondence: Linda M. McManus, Department of Pathology—MSC 7750, The University of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, TX 78229-3900. E-mail: mcmanus{at}uthscsa.edu

Inexplicable controversies with regard to possible functional defects of neutrophilic polymorphonuclear leukocytes (PMNs) in diabetes persist. The purpose of the present study was to elucidate the relative effectiveness of several PMN agonists in stimulating lysosomal-enzyme secretion and leukotriene (LT) B₄ production by PMNs isolated from diabetic subjects. Formyl-methionyl-leucyl-phenylalanine (fMLP) and platelet-activating factor (PAF) induced significantly less lysosomal-enzyme secretion and LTB₄ production in diabetic-subject PMNs than in normal-subject PMNs. It is surprising that PMNs from these same diabetic subjects responded normally after stimulation with A23187, serum-opsonized zymosan, or phorbol myristate acetate. The in vitro responsiveness of PMNs stimulated with fMLP or PAF was inversely correlated with indices of in vivo glycemic control (fasting plasma glucose and glycated-hemoglobin levels). In combination, these results indicate that hyperglycemia is associated with sustained decreases in PMN function but only in response to agonists that initiate stimulus-response coupling via G-protein-coupled receptors. This agonist-selective reduction in PMN responsiveness may contribute to the compromised host defense associated with sustained hyperglycemia in diabetes.

Key Words: fMLP • GPCR • inflammation • LTB4 • PAF

This article has been cited by other articles:

				R. J. Comi, J. Jacoby, D. Basta, M. Wood, and J. Butterly Improving Glucose Management by Redesigning the Care of Diabetic Inpatients Using a Nurse Practitioner Service Clin. Diabetes, March 1, 2009; 27(2): 78 - 81. [Full Text] [PDF]

				I. J. Tsai, L. J. Beilin, I. B. Puddey, K. D. Croft, and A. Barden Impaired ex Vivo Leukotriene B4 Production Characterizes the Metabolic Syndrome and Is Improved after Weight Reduction J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4747 - 4752. [Abstract] [Full Text] [PDF]

				N. W. Cheung, B. Napier, C. Zaccaria, and J. P. Fletcher Hyperglycemia Is Associated With Adverse Outcomes in Patients Receiving Total Parenteral Nutrition Diabetes Care, October 1, 2005; 28(10): 2367 - 2371. [Abstract] [Full Text] [PDF]

				S. Clement, S. S. Braithwaite, M. F. Magee, A. Ahmann, E. P. Smith, R. G. Schafer, and I. B. Hirsch Management of Diabetes and Hyperglycemia in Hospitals Diabetes Care, February 1, 2004; 27(2): 553 - 591. [Full Text] [PDF]

				S. J. Finney, C. Zekveld, A. Elia, and T. W. Evans Glucose Control and Mortality in Critically Ill Patients JAMA, October 15, 2003; 290(15): 2041 - 2047. [Abstract] [Full Text] [PDF]

				T. W. Evans Hemodynamic and Metabolic Therapy in Critically Ill Patients N. Engl. J. Med., November 8, 2001; 345(19): 1417 - 1418. [Full Text] [PDF]